Commonwealth Equity Services’s BIOATLA INC BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-506
Closed -$4.07K 4427
2026
Q1
$4.07K Hold
506
﹤0.01% 4293
2025
Q4
$14.4K Hold
506
﹤0.01% 4254
2025
Q3
$17K Hold
506
﹤0.01% 4213
2025
Q2
$10K Hold
506
﹤0.01% 4232
2025
Q1
$9K Buy
506
+70
+16% +$1.5K ﹤0.01% 4151
2024
Q4
$13K Hold
436
﹤0.01% 4058
2024
Q3
$38K Hold
436
﹤0.01% 3957
2024
Q2
$30K Sell
436
-44
-9% -$5.24K ﹤0.01% 3936
2024
Q1
$83K Buy
480
+44
+10% +$5.47K ﹤0.01% 3830
2023
Q4
$54K Hold
436
﹤0.01% 3749
2023
Q3
$37K Hold
436
﹤0.01% 3685
2023
Q2
$65K Hold
436
﹤0.01% 3628
2023
Q1
$58K Buy
436
+36
+9% +$6.48K ﹤0.01% 3564
2022
Q4
$165K Buy
+400
New +$166K ﹤0.01% 3303
2022
Q3
Sell
-280
Closed -$39K 3670
2022
Q2
$39K Buy
+280
New +$44.6K ﹤0.01% 3516

Other funds holding BCAB

Commonwealth Equity Services's BCAB Position: Q2 2026 in Review

Commonwealth Equity Services sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 506 shares — an estimated $4.07K sold.

Commonwealth Equity Services first reported a position in BCAB in Q2 2022 and held it in 15 quarters. The position peaked at $165K in Q4 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Commonwealth Equity Services reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 506 BIOATLA INC shares in Q2 2026, an estimated $4.07K.
  • Commonwealth Equity Services first reported a position in BIOATLA INC in Q2 2022 and held it in 15 quarters.
  • Commonwealth Equity Services's BIOATLA INC position peaked at $165K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.